KÄÄPÄ Biotech

Private

KarjalohjaHealthcare & Life Scienceshttps://www.kaapabiotech.com/

Last Round

VC Round

Nov 13, 2025

Company Overview

KÄÄPÄ Biotech is a biotechnology company that specializes in the research, cultivation, and production of functional mushroom extracts for the nutraceutical and food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Supply Chain

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medicinal mushroomsfunctional mushroomsmushroom extractsmycologynutraceutical ingredientscontract manufacturingmushroom myceliumultrasonic extractionNordReleaseadaptogenssuperfood ingredientsprivate label supplementsbiotech supply chainnootropicsforest-based cultivation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KÄÄPÄ Biotech Comps

Public and private peers based on sector, stage, and business model.

KÄÄPÄ Biotech comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

KÄÄPÄ Biotech Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Nov 13, 2025
VC Round	Apr 15, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Eric Puro

CEO

Executive Team

Vesa Tiitinen

Group Chief Financial Officer And M&A Leader, Board Member

Executive Team

KÄÄPÄ Biotech Investors

Notable investors and investment history

KÄÄPÄ Biotech investors
Investor	Rounds
Zintinus	VC Round
PeakBridge	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 10, 2024
Web traffic grew 257% MoM (from 1.4K to 5K monthly visitors)
Jul 12, 2024
Headcount grew 38% QoQ (from 21 to 29 employees)

View all signals

KÄÄPÄ Biotech Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

KÄÄPÄ Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KÄÄPÄ Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersKarjalohja

Employee Range35

Year Founded2018

Last FundingNov 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.